Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma

ClinicalTrials.gov ID: NCT00667407

Public ClinicalTrials.gov record NCT00667407. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind Study to Determine the Efficacy of Levalbuterol Versus Racemic Albuterol in the Treatment of Acute Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To investigate the Efficacy and Safety of Levalbuterol versus Racemic Albuterol in the Treatment of Acute Asthma.

Study identification

NCT ID
NCT00667407
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
627 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2000 (Type not available)
Primary completion
Aug 2002 (Actual)
Completion
Aug 2002 (Actual)
Last update posted
Feb 22, 2012

2000 – 2002

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Not listed Hoover Alabama — —
Not listed Montgomery Alabama — —
Not listed Encinitas California — —
Not listed Fresno California — —
Not listed Oakland California — —
Not listed Torrance California — —
Not listed Colorado Springs Colorado — —
Not listed Gainesville Florida — —
Not listed Jacksonville Florida — —
Not listed Tampa Florida — —
Not listed Chicago Illinois — —
Not listed Metairie Louisiana — —
Not listed Ann Arbor Michigan — —
Not listed Detroit Michigan — —
Not listed Kansas City Missouri — —
Not listed St Louis Missouri — —
Not listed Red Bank New Jersey — —
Not listed Brooklyn New York — —
Not listed New Hyde Park New York — —
Not listed Syracuse New York — —
Not listed Rocky Mount North Carolina — —
Not listed Akron Ohio — —
Not listed Cleveland Ohio — —
Not listed Lake Oswego Oregon — —
Not listed Medford Oregon — —
Not listed Philadelphia Pennsylvania — —
Not listed Houston Texas — —
Not listed Salt Lake City Utah — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00667407, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2012 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00667407 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →